The world's first cure for Bekhterev’s disease will appear in the Krasnoyarsk Territory

The world's first drug from Bekhterev’s disease will receive patients from 45 regions of the country, including the Krasnoyarsk Territory, developed by Russian scientists. This was reported on the official website of the manufacturer.

Seniprutug is an innovative medicine that is potentially capable of stopping the immune -spacing process in the illness of the Bekhterev and prevent its progression. The drug was registered by the Ministry of Health in April last year, in the summer BIOCAD announced the release of the first batch into civilian circulation, and patients began therapy.

The medicine is administered strictly under the supervision of a doctor, and the decision on the appointment is made by the attending rheumatologist. Studies have shown that a remission occurs during the action of the drug in many patients. There are no analogues of the Seniprutuga in the world.

Add, ankylosing spondel (or aNkylosing spondylitis) is a chronic disease in which the body’s immune system mistakenly perceives cartilage tissue and joints as foreign elements. In Russia, there are more than 150 thousand people with this diagnosis.

It affects primarily the spine, joints and places of attachment of ligaments and tendons to bones (enterus). Gradually, the vertebrae of the vertebrae occurs among themselves, which leads to deformation of the spine and its transformation into a single motionless structure. Patients experience constant pain and experience difficulties with movement.